Tag : Cosette Pharmaceuticals

Clinical Research, Pharma & Healthcare Financing

Cosette Pharma Expands Portfolio with SYMPAZAN® Acquisition

Business Wire
by Business Wire017
— Adds Portfolio of Branded Products with $48.9 million in 2025 Net Sales and an Established Commercial Presence — — SYMPAZAN® Establishes a Neurology Rare Disease Footprint...